Active, not recruitingNot applicableNCT05794646

Community Intervention to Eliminate HCV Among People Who Use Drugs.

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ANRS, Emerging Infectious Diseases
Principal Investigator
Hélène Donnadieu, PhD
PCCEI
Intervention
Hybrid effectiveness-implementation study type 2(other)
Enrollment
3400 target
Eligibility
18 years · All sexes
Timeline
2023 – 2025

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05794646 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome →

← Back to all trials